Studies on ORC and double strand DNA break repair
Studies on ORC and double strand DNA break repair
批准号:
10328884
负责人:
Anindya Dutta
金额:
$31.48万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-25 至 2025-01-31
关键词:
ASF1A geneATAC-seqAffectBasal Cell Nevus SyndromeBindingBypassCDC6 geneCHEK1 geneCancer cell lineCell ProliferationCell SurvivalCell physiologyCellsChromatinComplementComplexDNADNA Double Strand BreakDNA RepairDNA biosynthesisDNA-PKcsDouble Strand Break RepairEnhancersEpigenetic ProcessEukaryotaGene ExpressionGene Expression RegulationGenesGeneticGenome StabilityGenomic InstabilityGrantHistonesHumanIndividualMCM2 geneMaintenanceMalignant NeoplasmsMammalian CellMammalsMapsMediatingMolecular ChaperonesMusNonhomologous DNA End JoiningNormal CellORC1L geneOncogenesPathway interactionsPeptide Initiation FactorsPhosphorylationPhosphotransferasesPlayPolycombProliferatingProtein FamilyProtein KinaseProteinsRadiation therapyReaderRegulationReplication InitiationReplication OriginResistanceRoleSignal TransductionSignal Transduction PathwayTestingTissuesTransformed Cell LineYeastscancer cellcell transformationchemotherapyflyhelicaseinhibitormutantnew therapeutic targetnovelorigin recognition complexprotein complexrecruitrepairedtranscriptome sequencing
中文摘要
修订后的摘要
真核生物的复制起始被认为依赖于一个六亚基的、依赖于ATP的蛋白质复合体,即起源识别复合体(Origin Recognition Complex,ORC),它在复制的起始处加载解旋酶MCM2-7。在这笔赠款的最后一个周期中,我们有了一个令人惊讶的发现,几个人类癌细胞株在缺少ORC的两个重要亚单位ORC1或ORC2的情况下继续增殖和复制它们的DNA。这项提议将测试癌细胞系是通过残缺的ORC(ORC缺失一个亚基)的作用存活下来,还是因为细胞转化激活了一种替代的解旋酶加载机制,允许在缺少六个亚基的ORC的情况下加载MCM2-7。该提案还将确定人类ORC如何激活和抑制染色质的致密性,从而调节基因表达。它将测试ORC的各个亚基是否只作为复杂的ORC或作为独立于全息ORC的单个蛋白质具有这方面的功能。这些结果将阐明ORC在癌细胞复制启动和维持基因组稳定性中的重要性,识别ORC旁路机制,并识别ORC在调节细胞生理中的复制无关功能。
英文摘要
REVISED ABSTRACT
Replication initiation in eukaryotes is believed to be dependent on a six subunit, ATP-dependent complex of proteins, the Origin Recognition Complex (ORC), which loads the helicase MCM2-7 at origins of replication. In the last cycle of this grant we made the surprising discovery that several human cancer cell lines continue to proliferate and replicate their DNA in the absence of two important subunits of ORC, ORC1 or ORC2. This proposal will test whether cancer cell-lines survive through the action of a crippled ORC (ORC missing one subunit), or because cell transformation activates an alternate helicase-loading mechanism that allows MCM2-7 loading in the absence of the six subunit ORC. The proposal will also identify how human ORC activates and represses the compactness of the chromatin and thus regulate gene expression. It will test whether the individual subunits of ORC have functions in this regard only as the complex ORC or as individual proteins independent of the holo-ORC. The results will delineate the importance of ORC in replication initiation and maintenance of genome stability in cancer cells, identify ORC-bypass mechanisms and identify replication-independent functions of ORC in regulating cell physiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Involvement of Noncanonical Short RNAs in gene repression through the RNA-induced-silencing complex
-
批准号:10701797
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2022
-
负责人:Anindya Dutta
-
依托单位:
Studies on ORC and double strand DNA break repair
-
批准号:10377840
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2021
-
负责人:Anindya Dutta
-
依托单位:
Studies on ORC and double strand DNA break repair
-
批准号:10555198
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2021
-
负责人:Anindya Dutta
-
依托单位:
Mechanism of action of an lncRNA for directing muscle differentiation
-
批准号:10396900
-
项目类别:
-
资助金额:$21.39万
-
财政年份:2016
-
负责人:Anindya Dutta
-
依托单位:
Mechanism of action of an lncRNA for directing muscle differentiation
-
批准号:9914219
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2016
-
负责人:Anindya Dutta
-
依托单位:
Effect of anti-S phase agents on human chromosomes
-
批准号:8436839
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2013
-
负责人:Anindya Dutta
-
依托单位:
Effect of anti-S phase agents on human chromosomes
-
批准号:8608500
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2013
-
负责人:Anindya Dutta
-
依托单位:
Effect of anti-S phase agents on human chromosomes
-
批准号:8997926
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2013
-
负责人:Anindya Dutta
-
依托单位:
Androgen and MicroRNAs in Prostate Cancer
-
批准号:8038178
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2011
-
负责人:Anindya Dutta
-
依托单位:
MicroRNAs in differentiation of muscle
-
批准号:7883986
-
项目类别:
-
资助金额:$10.73万
-
财政年份:2009
-
负责人:Anindya Dutta
-
依托单位:
Function of RVB1-Tip60 in the DNA damage response
-
批准号:8118466
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2008
-
负责人:Anindya Dutta
-
依托单位:
Function of RVB1-Tip60 in the DNA damage response
-
批准号:7882310
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2008
-
负责人:Anindya Dutta
-
依托单位:
Regulation of TIP60 by the ubiquitin-proteasome pathway
-
批准号:8928632
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2008
-
负责人:Anindya Dutta
-
依托单位:
Regulation of TIP60 by the ubiquitin-proteasome pathway
-
批准号:8760396
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2008
-
负责人:Anindya Dutta
-
依托单位:
Function of RVB1-Tip60 in the DNA damage response
-
批准号:7581450
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2008
-
负责人:Anindya Dutta
-
依托单位:
Regulation of TIP60 by the ubiquitin-proteasome pathway
-
批准号:9279141
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2008
-
负责人:Anindya Dutta
-
依托单位:
Function of RVB1-Tip60 in the DNA damage response
-
批准号:7690342
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2008
-
负责人:Anindya Dutta
-
依托单位:
Screen for TIP60 Inhibitors
-
批准号:7289666
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2007
-
负责人:Anindya Dutta
-
依托单位:
MicroRNAs in differentiation of muscle
-
批准号:7494038
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2007
-
负责人:Anindya Dutta
-
依托单位:
MicroRNAs in differentiation of muscle
-
批准号:7885333
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2007
-
负责人:Anindya Dutta
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: